This site is intended for healthcare professionals

Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro.

Read time: 1 mins
Last updated:28th Jul 2021
Published:2nd Jul 2021
Royal Philips announced FDA 510k-clearance of real-time 3D intracardiac echocardiography (ICE) VeriSight Pro catheter which has the potential to improve standard of care for structural heart disease and electrophysiology procedures.
Condition: Left Atrial Appendage Occlusion (LAAO) procedure
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest